Medtronic posts Q4 profit beat on surgical instruments business strength


Employees work on stent graft components in a sterile environment at the Medtronic assembly plant in Tijuana, Mexico.

David Maung | Bloomberg | Getty Images

Medtronic reported a nearly 20% drop in quarterly profit on Thursday, hurt by lower sales in its cardiac and vascular business that makes heart valves and stents.

Net income attributable to the company fell to $1.17 billion, or 87 cents per share, in the fourth quarter ended April 26, from $1.46 billion, or $1.07 per share, a year earlier.

Net sales rose to $8.15 billion from $8.14 billion.

Products You May Like

Articles You May Like

SpaceX raised more than the $500 million it was seeking in its most recent funding round
Domino’s U.S. same-store sales rose 14% in first two months of the quarter
Older Adults Learning Online Too, As OLLI And One Day University Move To Zoom
NJ restaurant owner: Just because businesses can reopen does not mean they will survive
Dow Up 200 Points Even After Another 2.1 Million Job Losses

Leave a Reply

Your email address will not be published. Required fields are marked *